查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467694

2024-2032 年按類型、設備類型（實驗室設備、照護端設備）、最終用戶（實驗室測試、照護端測試）和地區分類的性傳染病診斷市場報告

Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type (Laboratory Devices, Point of Care Devices), End User (Laboratory Testing, Point of Care Testing), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球性傳染病（STD）診斷市場規模達1,041億美元。性病患病率的上升、大眾對早期診斷的認知不斷提高以及家庭性病檢測試劑盒的推出是推動市場發展的一些關鍵因素。

性傳染病 (STD) 診斷是指為識別和確認 STD 的存在而進行的檢查、測試和拭子培養。它包括血液、體液樣本和尿液檢測，以檢測某些 STD 的抗體或抗原的存在。廣泛用於檢測和篩檢各種性傳染病和感染，如生殖器皰疹、披衣菌、淋病、梅毒、陰蝨、滴蟲病、愛滋病、細菌性陰道炎、疥瘡、軟下疳等。性病診斷有助於早期發現和準確治療，預防不孕症，保護未出生的孩子免受感染，並最大限度地減少疾病傳播。這些診斷方法還有助於減少長期風險的機會，增強信心，並為醫生提供有關疾病及其原因的寶貴見解。

性傳染病 (STD) 診斷市場趨勢：

由於無保護性交和藥物濫用導致的性傳染病（STD）盛行率不斷上升是推動市場成長的關鍵因素之一。性傳染病診斷廣泛用於檢測各種引起性傳染病的病原體，如細菌、病毒和寄生蟲，具有高精度和可靠性，可幫助醫療保健提供者確定合適的治療方法，防止疾病從母親傳染給嬰兒，並改善患者的臨床結果。除此之外，大眾對早期發現和診斷性傳播疾病的認知不斷提高，這可以預防長期併發症，如不孕症、先天性殘疾、癌症、失明、骨骼畸形、腦損傷和智力低下，正在發揮作用。此外，政府採取各種措施來提高人們對性健康和性病檢測的認知，並透過教育活動、研討會和社群媒體廣告消除與之相關的社會恥辱，這也推動了市場的成長。此外，經濟高效、安全、準確、方便、提供更快結果並維護隱私的家用性病檢測套件的推出對市場成長產生了積極影響。此外，最近開發的基於人工智慧（AI）的行動應用程式可以透過分析個人隱私部位的數位影像來診斷性傳播疾病，從而改善性傳染病篩檢的機會，維護機密性並保護個人資料，有利於市場的成長。其他因素，包括醫療保健行業的顯著成長、在電子商務平台上輕鬆獲得性傳播疾病診斷試劑盒以及增加對新型診斷技術研發（R&D）的投資，預計將推動市場成長。

本報告回答的關鍵問題：

  • 迄今為止，全球性傳染病 (STD) 診斷市場的表現如何，未來幾年將如何表現？
  • 全球性傳染病 (STD) 診斷市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球性傳染病 (STD) 診斷市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的性傳染病 (STD) 診斷市場？
  • 依類型分類市場是怎麼樣的？
  • 性傳染病 (STD) 診斷市場中哪種類型最具吸引力？
  • 根據設備類型分類的市場是怎麼樣的？
  • 性傳染病 (STD) 診斷市場中最具吸引力的設備類型是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 性傳染病 (STD) 診斷市場中哪一個是最具吸引力的最終用戶？
  • 全球性傳染病（STD）診斷市場的競爭結構如何？
  • 全球性傳染病 (STD) 診斷市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球性傳染病 (STD) 診斷市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 衣原體檢測
    • 市場走向
    • 市場預測
  • 梅毒檢測
    • 市場走向
    • 市場預測
  • 淋病檢測
    • 市場走向
    • 市場預測
  • 單純皰疹病毒檢測
    • 市場走向
    • 市場預測
  • 人類乳突病毒檢測
    • 市場走向
    • 市場預測
  • 人類免疫缺乏病毒檢測
    • 市場走向
    • 市場預測
  • 軟下疳測試
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按設備類型

  • 實驗室設備
    • 市場走向
    • 關鍵環節
      • 熱循環儀 - PCR
      • 側向層析閱讀器
      • 流式細胞儀
      • 吸光度酶標儀 - 酵素連結免疫吸附測定 (ELISA)
      • 其他
    • 市場預測
  • 照護端 (PoC) 設備
    • 市場走向
    • 關鍵環節
      • 手機晶片（微流體+ICT）
      • 攜帶式/桌上型/快速診斷套件
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 實驗室測試
    • 市場走向
    • 市場預測
  • 照護端測試
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • BioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Cepheid (Danaher Corporation)
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • Qiagen NV
    • Quidel Corporation
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112024A6956

The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. The rising prevalence of STDs, increasing awareness among the masses regarding early diagnosis, and the introduction of at-home STD testing kits represent some of the key factors driving the market.

Sexually transmitted disease (STD) diagnostics refer to examinations, tests, and swab cultures performed to identify and confirm the presence of STDs. It includes blood, fluid sample, and urine tests to detect the presence of antibodies or antigens of certain STDs. It is widely used to detect and screen various sexually transmitted diseases and infections, such as genital herpes, chlamydia, gonorrhea, syphilis, pubic lice, trichomoniasis, acquired immune deficiency syndrome (AIDS), bacterial vaginosis, scabies, and chancroid. STD diagnostics aids in early detection and accurate treatment, prevents infertility, protects unborn children from infection, and minimizes the spread of diseases. These diagnostic methods also help in reducing the chance of long-term risks, boosting confidence, and providing physicians with valuable insight into diseases and their causes.

Sexually Transmitted Disease (STD) Diagnostics Market Trends:

The rising prevalence of sexually transmitted diseases (STDs) due to unprotected sexual intercourse and drug abuse is one of the key factors driving the market growth. STD diagnostics are widely used to detect various STD-causing agents, such as bacteria, viruses, and parasites, with high accuracy and reliability that aids healthcare providers in determining suitable treatment, preventing disease transmission from mothers to infants, and improving clinical outcomes for patients. In addition to this, the increasing awareness among the masses regarding early detection and diagnosis of STDs, which can prevent long-term complications, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to the market growth. Additionally, the introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the market growth. Moreover, the recent development of artificial intelligence (AI) - based mobile applications that can diagnose STDs by analyzing digital images of an individual's private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development (R&D) of novel diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global sexually transmitted disease (STD) diagnostics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, device type, and end user.

Type Insights:

Chlamydia Testing

Syphilis Testing

Gonorrhea Testing

Herpes Simplex Virus Testing

Human Papilloma Virus Testing

Human Immunodeficiency Virus Testing

Chancroid Testing

Others

The report has provided a detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the type. This includes chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus, chancroid testing, and others. According to the report, chlamydia testing represented the largest segment.

Device Type Insights:

Laboratory Devices

Thermal Cycler - PCR

Lateral Flow Readers

Flow Cytometers

Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)

Others

Point of Care (PoC) Devices

Phone Chips (Microfluidics + ICT)

Portable/Bench Top/Rapid Diagnostic Kits

A detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the device type has also been provided in the report. This includes laboratory devices (thermal cycler - PCR, lateral flow readers, flow cytometers, absorbance microplate reader - enzyme linked immunosorbent assay (ELISA), and others) and point of care (PoC) devices (phone chips (microfluidic + ICT) and portable/bench top/rapid diagnostic kits). According to the report, laboratory devices accounted for the largest market share.

End User Insights:

Laboratory Testing

Point of Care (PoC) Testing

A detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the end user has also been provided in the report. This includes laboratory and point of care (PoC) testing. According to the report, laboratory testing accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for sexually transmitted disease (STD) diagnostics. Some of the factors driving the North America sexually transmitted disease (STD) diagnostics market included the rising prevalence of STDs, extensive research and development (R&D) activities, and significant growth in the healthcare industry.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global sexually transmitted disease (STD) diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global sexually transmitted disease (STD) diagnostics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global sexually transmitted disease (STD) diagnostics market?
  • What is the impact of each driver, restraint, and opportunity on the global sexually transmitted disease (STD) diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the device type?
  • Which is the most attractive device type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the sexually transmitted disease (STD) diagnostics market?
  • What is the competitive structure of the global sexually transmitted disease (STD) diagnostics market?
  • Who are the key players/companies in the global sexually transmitted disease (STD) diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sexually Transmitted Disease (STD) Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Chlamydia Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Syphilis Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gonorrhea Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Herpes Simplex Virus Testing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Human Papilloma Virus Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Human Immunodeficiency Virus Testing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Chancroid Testing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Laboratory Devices
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Thermal Cyclers - PCR
      • 7.1.2.2 Lateral Flow Readers
      • 7.1.2.3 Flow Cytometers
      • 7.1.2.4 Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Point of Care (PoC) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Phone Chips (Microfluidics + ICT)
      • 7.2.2.2 Portable/Bench Top/Rapid Diagnostic Kits
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Laboratory Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Point of Care Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 BioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid (Danaher Corporation)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Hologic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Qiagen N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Quidel Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens Healthineers AG (Siemens AG)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Sexually Transmitted Disease Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Device Type (in %), 2023
  • Figure 6: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Sexually Transmitted Disease Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Sexually Transmitted Disease Diagnostics Industry: Value Chain Analysis
  • Figure 83: Global: Sexually Transmitted Disease Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sexually Transmitted Disease Diagnostics Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Device Type (in Million US$), 2024-2032
  • Table 4: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Sexually Transmitted Disease Diagnostics Market: Competitive Structure
  • Table 7: Global: Sexually Transmitted Disease Diagnostics Market: Key Players